ISSN 2590-0048
Vol. 3, Issue 1, 2021March 23, 2021 CDT
Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma
Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma
Articles in Vol. 3, Issue 1, 2021
Vol. 3, Issue 1, 2021
- Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell LymphomaRita AssiNohad MasriIman Abou DalleJean El-CheikhHady GhanemAli Bazarbachi
- One Year into the COVID-19 PandemicMohamad MohtyJunia V. Melo
- Machine Learning Applications in the Diagnosis of Benign and Malignant Hematological DiseasesIbrahim N. Muhsen
1.
Assi R, Masri N, Abou Dalle I, El-Cheikh J, Ghanem H, Bazarbachi A. Polatuzumab Vedotin: Current Role and Future Applications in the Treatment of Patients with Diffuse Large B-Cell Lymphoma. Clinical Hematology International. 2021;3(1). doi:10.2991/chi.k.210305.001. PMID:34595463